Johnson & Johnson JNJ
NYSE JNJ
$269.99 -0.22 (-0.08%)
At close: Sep 18, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Net Shares Issued and Repurchased (2010 - 2012)

Johnson & Johnson's (JNJ) quarterly Net Shares Issued and Repurchased came in at $1.9 million in Q1 2012, down 17.86% year-over-year from $2.3 million in Q1 2011, and down 17.86% quarter-over-quarter from $2.3 million in Q1 2011.

Analysis

Johnson & Johnson (JNJ) Net Shares Issued and Repurchased (2010 - 2012) Analysis & Trends

Johnson & Johnson has disclosed Net Shares Issued and Repurchased across 3 years of filings, most recently posting $1.9 million for Q1 2012.

  • In Q1 2012, Net Shares Issued and Repurchased fell 17.86% year-over-year to $1.9 million; the TTM figure through Jan 2012 stood at $1.9 million (down 17.86% YoY), while the FY2012 annual figure was $1.9 million, down 17.86% from the prior year.
  • Net Shares Issued and Repurchased came in at $1.9 million for Q1 2012 at Johnson & Johnson, down from $2.3 million in the prior quarter.
  • In the past five years, Net Shares Issued and Repurchased ranged from a high of $2.3 million in Q1 2011 to a low of $1.4 million in Q1 2010.
  • Average Net Shares Issued and Repurchased over 3 years is $1.9 million, with a median of $1.9 million recorded in 2012.
  • Year-over-year, Net Shares Issued and Repurchased soared 64.94% in 2011 and declined 17.86% in 2012.
  • Over 3 years, Net Shares Issued and Repurchased stood at $1.4 million in 2010, then surged by 64.94% to $2.3 million in 2011, then declined by 17.86% to $1.9 million in 2012.
  • Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.9 million in Q1 2012, $2.3 million in Q1 2011, and $1.4 million in Q1 2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Shares Issued and Repurchased (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -3.07 Bn
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Incyte 25.18 Bn 20.65 Bn 1.57 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jan 1, 2012 1.89 Mn
Jan 2, 2011 2.30 Mn
Jan 3, 2010 1.39 Mn